Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Dermatologic Agents"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 8533
Tytuł:
A dermocosmetic regimen is able to mitigate skin sensitivity induced by a retinoid-based fixed combination treatment for acne: Results of a randomized clinical trial.
Autorzy:
Khammari A; Department of Dermatology, Nantes University, CHU Nantes, CIC 1413, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, Nantes, France.
Kerob D; La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France.
Demessant AL; La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France.
Nioré M; La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France.
Dréno B; Nantes University, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, Nantes, France.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Apr; Vol. 23 (4), pp. 1313-1319. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Dermatologic Agents*/adverse effects
Acne Vulgaris*/drug therapy
Female ; Humans ; Young Adult ; Adult ; Male ; Retinoids/therapeutic use ; Naphthalenes/therapeutic use ; Benzoyl Peroxide ; Adapalene/therapeutic use ; Drug Combinations ; Treatment Outcome ; Gels
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation.
Autorzy:
Naumowicz M; Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.
Modzelewski S; Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.
Macko A; Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.
Łuniewski B; Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.
Baran A; Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.
Flisiak I; Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 20; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Necrobiosis Lipoidica*/diagnosis
Necrobiosis Lipoidica*/drug therapy
Necrobiosis Lipoidica*/etiology
Diabetes Mellitus, Type 1*/complications
Dermatologic Agents*/therapeutic use
Biological Products*/therapeutic use
Humans ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The efficacy and safety of deucravacitinib compared to methotrexate, in patients with vulvar lichen planus who have failed topical therapy with potent corticosteroids: a study protocol for a single-centre double-blinded randomised controlled trial.
Autorzy:
Wijaya M; Department of Dermatology, Royal North Shore Hospital, Reserve Rd, St Leonards, New South Wales, Australia. .; The University of Sydney, Northern Clinical School, St Leonards, New South Wales, Australia. .
Fischer G; Department of Dermatology, Royal North Shore Hospital, Reserve Rd, St Leonards, New South Wales, Australia.; The University of Sydney, Northern Clinical School, St Leonards, New South Wales, Australia.
Saunderson RB; Department of Dermatology, Royal North Shore Hospital, Reserve Rd, St Leonards, New South Wales, Australia.; The University of Sydney, Northern Clinical School, St Leonards, New South Wales, Australia.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 12; Vol. 25 (1), pp. 181. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Dermatologic Agents*/adverse effects
Heterocyclic Compounds*
Lichen Planus*/chemically induced
Lichen Planus*/drug therapy
Female ; Humans ; Adrenal Cortex Hormones/adverse effects ; Australia ; Folic Acid ; Glucocorticoids ; Methotrexate/adverse effects ; Quality of Life ; Randomized Controlled Trials as Topic ; Tablets ; Treatment Outcome ; Adolescent ; Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The efficiency and safety of low-dosage isotretinoin therapy for Chinese acne vulgaris patients.
Autorzy:
Li Y; Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zeng Y; Department of Dermatology, Minhang Hospital, Fudan University, Shanghai, China.
Chen Z; Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Nie S; Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wu Z; Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Mar; Vol. 23 (3), pp. 926-930. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*
Acne Vulgaris*/drug therapy
Skin Diseases*/drug therapy
Humans ; Isotretinoin ; Treatment Outcome ; Administration, Oral ; China
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of a multitargeted, salicylic acid-based dermocosmetic cream compared to benzoyl peroxide 5% in Acne vulgaris: Results from a randomized study.
Autorzy:
Dal Belo SE; L'Oréal Research and Innovation, Aulnay-Sous-Bois, France.
Kanoun-Copy L; L'Oréal Research and Innovation, Clichy, France.
Lambert C; L'Oréal, Research and Innovation, Chevilly-Larue, France.
Cornillon C; L'Oréal, Research and Innovation, Chevilly-Larue, France.
Muller B; L'Oréal Research and Innovation, Clichy, France.
Jouni H; L'Oréal Research and Innovation, Aulnay-Sous-Bois, France.
Moreau M; L'Oréal Research and Innovation, Aulnay-Sous-Bois, France.
Palamarchuk I; Cosmetest Vidnovlennya, Zhytomir, Ukraine.
Kerob D; La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France.
Aguilar L; L'Oréal Research and Innovation, Aulnay-Sous-Bois, France.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Mar; Vol. 23 (3), pp. 891-897. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Acne Vulgaris*/drug therapy
Acne Vulgaris*/pathology
Dermatologic Agents*/therapeutic use
Female ; Humans ; Male ; Benzoyl Peroxide/therapeutic use ; Drug Combinations ; Gels ; Salicylic Acid/therapeutic use ; Treatment Outcome ; Adolescent ; Young Adult ; Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Brilaroxazine lipogel displays antipsoriatic activity in imiquimod-induced mouse model.
Autorzy:
Bhat L; Reviva Pharmaceuticals, Inc., Cupertino, California, USA.
Bhat SR; Reviva Pharmaceuticals, Inc., Cupertino, California, USA.
Ramakrishnan A; Reviva Pharmaceuticals, Inc., Cupertino, California, USA.
Amirthalingam M; Reviva Pharmaceuticals, Inc., Cupertino, California, USA.
Pokaż więcej
Źródło:
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2024 Feb; Vol. 30 (2), pp. e13606.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/chemically induced
Psoriasis*/drug therapy
Dermatologic Agents*/pharmacology
Animals ; Mice ; Imiquimod/adverse effects ; Ki-67 Antigen/metabolism ; Serotonin/metabolism ; Serotonin/pharmacology ; Serotonin/therapeutic use ; Skin/pathology ; Cytokines/metabolism ; Cytokines/pharmacology ; Cytokines/therapeutic use ; Transforming Growth Factor beta/metabolism ; Transforming Growth Factor beta/pharmacology ; Transforming Growth Factor beta/therapeutic use ; Disease Models, Animal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study.
Autorzy:
Dou X; Department of Dermatology, Peking University First Hospital, Beijing, China.
Liu L; Department of Dermatology, Peking University First Hospital, Beijing, China.
Zhu X; Department of Dermatology, Peking University First Hospital, Beijing, China.
Wen W; Department of Dermatology, Peking University First Hospital, Beijing, China.
Ni C; Department of Dermatology, Peking University First Hospital, Beijing, China.
Zhao Y; Department of Dermatology, Peking University First Hospital, Beijing, China.
He Z; Department of Dermatology, Peking Union Medical College Hospital, Beijing, China.
Li H; Department of Dermatology, Peking Union Medical College Hospital, Beijing, China.
Sun Q; Department of Dermatology, Peking Union Medical College Hospital, Beijing, China.
Yang Q; Department of Dermatology, Shanghai Huashan Hospital, Shanghai, China.
Sun X; Department of Dermatology, Shanghai Huashan Hospital, Shanghai, China.
Guo Y; Department of Dermatology, Shanghai XinHua Hospital, Shanghai, China.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2229464.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Dermatologic Agents*/administration & dosage
Dermatologic Agents*/adverse effects
Dermatologic Agents*/therapeutic use
Tacrolimus*/administration & dosage
Tacrolimus*/adverse effects
Tacrolimus*/analogs & derivatives
Tacrolimus*/therapeutic use
Humans ; Infant ; East Asian People ; Treatment Outcome ; Administration, Topical ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Glucocorticoids/therapeutic use ; Skin Cream
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Resolving acne with optimized adapalene microspongeal gel, in vivo and clinical evaluations.
Autorzy:
Yehia RM; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt (BUE), Suez Desert Road, El Sherouk City, Cairo, 1183, Egypt. .
Teaima MH; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Ragaie MH; Department of Dermatology, STDs and Andrology, Faculty of Medicine, Minia University, Al Minya, Egypt.
Elmazar MM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt.
Attia DA; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt (BUE), Suez Desert Road, El Sherouk City, Cairo, 1183, Egypt.
El-Nabarawi MA; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1359. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Acne Vulgaris*/drug therapy
Acne Vulgaris*/pathology
Dermatologic Agents*/therapeutic use
Humans ; Mice ; Animals ; Adapalene ; Skin/pathology ; Polymers/therapeutic use ; Treatment Outcome ; Gels/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness.
Autorzy:
Ninosu N; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Hoelker S; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Kappenstein M; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Buettner S; Department of Biomathematics and Medical Statistics, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
Peitsch WK; Department of Dermatology and Phlebology, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
Schaarschmidt ML; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2200570.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*/adverse effects
Psoriasis*/therapy
Humans ; Male ; Middle Aged ; Female ; Patient Satisfaction ; Surveys and Questionnaires ; Administration, Cutaneous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice.
Autorzy:
van der Schoot LS; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Janssen JJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Bastiaens MT; Department of Dermatology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands.
de Boer-Brand A; Department of Dermatology, St Antonius Ziekenhuis, Nieuwegein, The Netherlands.
Christiaansen-Smit C; Department of Dermatology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands.
Enomoto DNH; Department of Dermatology, Dermatologisch Centrum Isala, Zwolle, The Netherlands.
Hovingh R; Department of Dermatology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands.
Tupker RA; Department of Dermatology, St Antonius Ziekenhuis, Nieuwegein, The Netherlands.
Seyger MMB; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Verhoef LM; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.
van den Reek JMPA; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
de Jong EMGJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud University, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2186728.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*/therapeutic use
Psoriasis*/drug therapy
Biological Products*/therapeutic use
Humans ; Etanercept/therapeutic use ; Ustekinumab/therapeutic use ; Adalimumab/therapeutic use ; Drug Tapering
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Macrocystis pyrifera ferment-containing creams for optimizing facial skin rejuvenation.
Autorzy:
Gold M; Gold Skin Care Center, Nashville, Tennessee, USA.
Bae YC; Laser & Skin Surgery Center of New York, New York, New York, USA.
Goldberg DJ; Schweiger Dermatology Group, Hackensack, New Jersey, USA.; Icahn School of Medicine at Mt. Sinai, New York, New York, USA.
Jamal S; Schweiger Dermatology Group, New York, New York, USA.
Lewis AB; Lewis Dermatology & Associates, New York, New York, USA.
Marchbein S; NYU School of Medicine, New York, New York, USA.
Ros A; Dermatology Institute and Laser Center, Clifton, New Jersey, USA.
Santhanam U; The Estee Lauder Companies, Melville, New York, USA.
DiNatale L; The Estee Lauder Companies, Melville, New York, USA.; La Mer, Max Huber Research Labs, Melville, New York, USA.
Emmetsberger J; The Estee Lauder Companies, Melville, New York, USA.; La Mer, Max Huber Research Labs, Melville, New York, USA.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2023 Dec; Vol. 22 (12), pp. 3313-3319.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Macrocystis*
Dermatologic Agents*
Skin Aging*
Humans ; Rejuvenation ; Skin ; Epidermis ; Anti-Inflammatory Agents
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ocular side effects of systemic isotretinoin - a systematic review and summary of case reports.
Autorzy:
Lamberg O; Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA.
Strome A; Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA.
Jones F; Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Mleczek J; College of Literature, Science and Arts, University of Michigan, Ann Arbor, MI, USA.
Jarocki A; Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA.
Troost JP; Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI, USA.
Helfrich Y; Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2213364.
Typ publikacji:
Case Reports; Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Acne Vulgaris*/drug therapy
Dermatologic Agents*/adverse effects
Drug-Related Side Effects and Adverse Reactions*/drug therapy
Dry Eye Syndromes*/chemically induced
Humans ; Eye ; Face ; Isotretinoin/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low irritation potential of tazarotene 0.045% lotion: Head-to-head comparison to adapalene 0.3% gel and trifarotene 0.005% cream in two studies.
Autorzy:
Draelos ZD; Dermatology Consulting Services, PLLC, High Point, NC, USA.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2166346.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Dermatologic Agents*/adverse effects
Acne Vulgaris*/drug therapy
Adult ; Humans ; Adapalene ; Naphthalenes ; Retinoids ; Emollients ; Double-Blind Method ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fixed-combination halobetasol propionate and tazarotene topical lotion decreases TNF-α and IL-17A levels in psoriatic lesions.
Autorzy:
Draelos ZD; Dermatology Consulting Services, High Point, NC, USA.
Draelos MM; Dermatology Consulting Services, High Point, NC, USA.
Lin T; Ortho Dermatologics (a division of Bausch Health US, LLC), Bridgewater, NJ, USA.
Jacobson A; Ortho Dermatologics (a division of Bausch Health US, LLC), Bridgewater, NJ, USA.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2245081.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*/therapeutic use
Psoriasis*/drug therapy
Adult ; Humans ; Tumor Necrosis Factor-alpha ; Interleukin-17 ; Drug Combinations ; Treatment Outcome ; Severity of Illness Index ; Skin Cream/therapeutic use ; Clobetasol/therapeutic use ; Emollients ; Emulsions ; Immunoglobulin A ; Double-Blind Method
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful treatment of rare linear lichen planopilaris with Ixekizumab.
Autorzy:
Ahmed H; Department of Dermatology & Venereology, Hamad Medical Corporation, Doha, Qatar.; Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
Petkar M; Department of Pathology, Hamad Medical Corporation, Doha, Qatar.
Steinhoff M; Department of Dermatology & Venereology, Hamad Medical Corporation, Doha, Qatar.; Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.; Department of Dermatology, Weill Cornell Medicine, New York, NY, USA.; School of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar.; School of Medicine, Qatar University, Doha, Qatar.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2201364.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Alopecia*/drug therapy
Lichen Planus*/drug therapy
Antibodies, Monoclonal, Humanized*/therapeutic use
Dermatologic Agents*/therapeutic use
Humans ; Hair ; Treatment Outcome
SCR Disease Name:
Lichen planus follicularis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin.
Autorzy:
Tanghetti EA; Center for Dermatology and Laser Surgery, Sacramento, CA, USA.
Zeichner JA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Gold M; Tennessee Clinical Research Center, Nashville, TN, USA.
Sadick N; Department of Dermatology, Weill Cornell Medical College, New York, NY, USA.; Sadick Dermatology, New York, NY, USA.
Cook-Bolden FE; Department of Dermatology, Weill Cornell Medical College, New York, NY, USA.; Fran E. Cook-Bolden, MD, PLLC, New York, NY, USA.
Kircik LH; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Dermatology, Indiana University Medical Center, Indianapolis, IN, USA.; Physicians Skin Care, PLLC, DermResearch, PLLC, and Skin Sciences, PLLC, Louisville, KY, USA.
Stein Gold L; Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA.
Weiss J; Georgia Dermatology Partners, Snellville, GA, USA.; Gwinnett Clinical Research Center, Inc, Snellville, GA, USA.
Tyring SK; Department of Dermatology, Health Science Center, University of Texas, Houston, TX, USA.
Del Rosso JQ; JDR Dermatology Research/Thomas Dermatology, Las Vegas, NV, USA.; Advanced Dermatology and Cosmetic Surgery, Maitland, FL, USA.; Department of Dermatology, Touro University Nevada, Henderson, NV, USA.
Guenin E; Ortho Dermatologics, Division of Bausch Health US, LLC, Ortho Dermatologics, Bridgewater, NJ, USA.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2147391.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Acne Vulgaris*/drug therapy
Acne Vulgaris*/pathology
Dermatologic Agents*/adverse effects
Humans ; Tretinoin/therapeutic use ; Keratolytic Agents/therapeutic use ; Quality of Life ; Severity of Illness Index ; Skin Cream/therapeutic use ; Administration, Cutaneous ; Treatment Outcome ; Double-Blind Method ; Emulsions
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Design and Evaluation of Tretinoin Fatty Acid Vesicles for the Topical Treatment of Psoriasis.
Autorzy:
Zhao Y; College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
Wang C; College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
Zou B; College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
Fu L; College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
Ren S; College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
Zhang X; College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Nov 30; Vol. 28 (23). Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/drug therapy
Psoriasis*/metabolism
Dermatologic Agents*/chemistry
Mice ; Animals ; Tretinoin/pharmacology ; Skin Absorption ; Fatty Acids/metabolism ; Prospective Studies ; Skin ; Particle Size ; Drug Carriers/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of a lotion containing probiotic ferment lysate as the main functional ingredient on enhancing skin barrier: a randomized, self-control study.
Autorzy:
Cui H; Qingdao Vland Biotech Co., Ltd., 596-1 Jiushui East Road, Laoshan District, Qingdao, 266102, China.
Feng C; Qingdao Vland Biotech Co., Ltd., 596-1 Jiushui East Road, Laoshan District, Qingdao, 266102, China.
Zhang T; Qingdao Vland Biotech Co., Ltd., 596-1 Jiushui East Road, Laoshan District, Qingdao, 266102, China.
Martínez-Ríos V; ADM, Nutrition, Health and Wellness, Biopolis S.L., Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980, Paterna, Spain.
Martorell P; ADM, Nutrition, Health and Wellness, Biopolis S.L., Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980, Paterna, Spain.
Tortajada M; ADM, Nutrition, Health and Wellness, Biopolis S.L., Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980, Paterna, Spain.
Cheng S; Qingdao Vland Biotech Co., Ltd., 596-1 Jiushui East Road, Laoshan District, Qingdao, 266102, China.
Cheng S; Qingdao Vland Biotech Co., Ltd., 596-1 Jiushui East Road, Laoshan District, Qingdao, 266102, China.
Duan Z; Qingdao Vland Biotech Co., Ltd., 596-1 Jiushui East Road, Laoshan District, Qingdao, 266102, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 06; Vol. 13 (1), pp. 16879. Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Dermatologic Agents*/pharmacology
Probiotics*/pharmacology
Humans ; Antioxidants/pharmacology ; Emollients/pharmacology ; Emollients/therapeutic use ; Skin ; Fibrinolytic Agents/therapeutic use ; Water/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Formulation and Evaluation of Deep Eutectic Vehicles for the Topical Delivery of Azelaic Acid for Acne Treatment.
Autorzy:
Luhaibi DK; Faculty of Pharmacy, Pharmacological and Diagnostic Research Center, Al-Ahliyya Amman University, Amman 19328, Jordan.
Ali HHM; Department of Pharmaceutics, College of Pharmacy, University of Sulaimani, Sulaimani 46001, Kurdistan Region, Iraq.
Al-Ani I; Faculty of Pharmacy, Pharmacological and Diagnostic Research Center, Al-Ahliyya Amman University, Amman 19328, Jordan.
Shalan N; Faculty of Pharmacy, Pharmacological and Diagnostic Research Center, Al-Ahliyya Amman University, Amman 19328, Jordan.
Al-Akayleh F; Faculty of Pharmacy and Medical Sciences, University of Petra, Amman 11196, Jordan.
Al-Remawi M; Faculty of Pharmacy and Medical Sciences, University of Petra, Amman 11196, Jordan.
Nasereddin J; Faculty of Pharmacy, Department of Pharmaceutical Sciences, Zarqa University, Zarqa 13110, Jordan.
Qinna NA; Faculty of Pharmacy and Medical Sciences, University of Petra, Amman 11196, Jordan.
Al-Adham I; Faculty of Pharmacy and Medical Sciences, University of Petra, Amman 11196, Jordan.
Khanfar M; Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Oct 04; Vol. 28 (19). Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*/therapeutic use
Acne Vulgaris*/drug therapy
Animals ; Rabbits ; Dicarboxylic Acids/chemistry ; Skin ; Pharmaceutical Preparations ; Choline/chemistry ; Solvents/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging.
Autorzy:
King S; Dermatica Institute of Clinical Excellence, London, UK.
Campbell J; Dermatica Institute of Clinical Excellence, London, UK.
Rowe R; Dermatica Institute of Clinical Excellence, London, UK.
Daly ML; Dermatica Institute of Clinical Excellence, London, UK.
Moncrieff G; Dermatica Institute of Clinical Excellence, London, UK.
Maybury C; Dermatica Institute of Clinical Excellence, London, UK.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2023 Oct; Vol. 22 (10), pp. 2650-2662. Date of Electronic Publication: 2023 Aug 07.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Skin Aging*
Acne Vulgaris*/drug therapy
Rosacea*/drug therapy
Rosacea*/pathology
Melanosis*/drug therapy
Dermatologic Agents*/adverse effects
Humans ; Erythema/drug therapy ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 8533

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies